Your browser doesn't support javascript.
loading
Baseline serum albumin is a predictive biomarker for patients with advanced pancreatic cancer treated with bevacizumab: a pooled analysis of 7 prospective trials of gemcitabine-based therapy with or without bevacizumab.
Pant, Shubham; Martin, Ludmila K; Geyer, Susan; Wei, Lai; Van Loon, Katherine; Sommovilla, Nili; Sommovilla, Nilli; Zalupski, Mark; Iyer, Renuka; Fogelman, David; Ko, Andrew H; Bekaii-Saab, Tanios.
Afiliação
  • Pant S; Division of Hematology and Oncology, Department of Medicine, University of Oklahoma, Oklahoma City, Oklahoma.
Cancer ; 120(12): 1780-6, 2014 Jun 15.
Article em En | MEDLINE | ID: mdl-24633933

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Albumina Sérica / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Albumina Sérica / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2014 Tipo de documento: Article